Bejon Misra Image

Bejon Misra, on right, talking to attendees of the 72nd FIP Symposium

[...]

Bejon Misra Moderating Panel at Interchange

Bejon Misra, Founder of The Partnership for Safe Medicines India, will be moderating the 1:45pm panel, “The Role of Patients and Healthcare Professionals,” at the Partnership for Safe Medicines Interchange on October 27, 2011.

Mr. Misra has been in the consumer empowerment policy advocacy and research for the last 27 years and is also the Managing Director & Trustee of the Consumer Online Foundation and Chairman of Cell for Consumer Education & Advocacy (CCEA) based in New Delhi, India.

“I am looking forward to the Interchange as it will enable me to further empower the consumers in developing countries to access safe medicines at the most affordable price in partnership with the global leaders,” said Mr. Misra.

Learn more about how agencies and industry fight medicine counterfeiting and sales at the 2011 Interchange on October 27 at the National Press Club.

PSM 2011 Interchange logo
Register for Partnership for Safe Medicines 2011 Interchange in Washington DC, on Eventbrite

[...]

Merck Sponsors the Interchange

Merck is a global healthcare leader working to help the world be well. Merck is known as MSD outside the United States and Canada.

Through its prescription medicines, vaccines, biologic therapies, and consumer care and animal health products, it work with customers and operate in more than 140 countries to deliver innovative health solutions. It also demonstrate its commitment to increasing access to healthcare through far-reaching policies, programs and partnerships.

Learn more about how agencies and industry fight medicine counterfeiting and sales at the 2011 Interchange on October 27 at the National Press Club.

 

PSM 2011 Interchange logo
Register for Partnership for Safe Medicines 2011 Interchange in Washington DC, on Eventbrite

[...]

Alex Dahl to Speak on Panel at The Partnership for Safe Medicines Interchange 2011

Alex Dahl will speak on the panel, “Protecting Our Medicines.” He is a member of The Coalition for Patient Safety and Medicine Integrity which is a group of pharmaceutical, medical device and medical products companies focused on patient safety.

Its purpose is to protect patients from the risks posed by stolen and inappropriately handled medical products re-entering the legitimate supply chain. The Coalition includes: Abbott Laboratories, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Novartis, Novo Nordisk, Sanofi Aventis, and PhRMA.

[...]

Partnership for Safe Medicines Opposes Legislation to Undermine Drug Safety Enforcements

Public Health Group Urges Senators to Prevent Influx of Counterfeit Medicines and Ensure Patient Safety by Opposing Vitter Importation Amendment Washington, D.C. (October 19, 2011) – Legislation that would prohibit the US Food and Drug Administration (FDA) from stopping the importation of potentially unsafe medicines, including those sold over the Internet, would raise the risk…

[...]

Sen. Vitter’s Proposed Amendment Raises Drug Safety Concerns

[The Senate is marking up the House's Agricultural Appropriations Bill (HR 2112).  They are considering an amendment (#769) proposed by Senator Vitter which would allow for drug importation.  The Partnership for Safe Medicines sent this letter to all members of the Senate today to urge them to oppose importation.] Dear Senator,  As a public health group…

[...]

Researchers Show Fake Medicine Spammers Infiltrating Twitter

A new study by the University of Akron shows Twitter is a new forum for spammers to reach potential clients in counterfeit medicine scams. Say researchers Chandra Shekar, Kathy J. Liszka, and Chien-Chung Chan, “Spammers have pounced on this new opportunity for a fast and dishonest dollar, disseminating pornography, fake lotteries, fake inheritances, counterfeit watches,…

[...]

Teva Pharmaceutical Industries Sponsors Partnership for Safe Medicines Interchange 2011

Teva Pharmaceutical Industries Ltd. is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Headquartered in Israel, Teva is the world’s largest generic drug maker, with a global product portfolio of more than…

[...]